These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9627975)

  • 21. GC-MS studies on the regioisomeric 2,3- and 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB.
    Thigpen A; DeRuiter J; Clark CR
    J Chromatogr Sci; 2007; 45(5):229-35. PubMed ID: 17555628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
    Parrott AC
    Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the precursors, intermediates and reaction by-products in the synthesis of 3,4-methylenedioxymethylamphetamine and its application to forensic drug analysis.
    Renton RJ; Cowie JS; Oon MC
    Forensic Sci Int; 1993 Aug; 60(3):189-202. PubMed ID: 7901132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and simple method for direct determination of several amphetamines in seized tablets by GC--FID.
    Mitrevski B; Zdravkovski Z
    Forensic Sci Int; 2005 Sep; 152(2-3):199-203. PubMed ID: 15978345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectrometry method.
    Visser HA; Visser-van Leeuwen M; Huizer H
    Bull Narc; 2005; 57(1-2):167-82. PubMed ID: 21338020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid analysis of illicit drugs by mass spectrometry: results from seizures in Ireland.
    O'Connell D; Heffron JJ
    Analyst; 2000 Jan; 125(1):119-21. PubMed ID: 10885070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
    Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
    Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration?
    Vidal Giné C; Ventura Vilamala M; Fornís Espinosa I; Gil Lladanosa C; Calzada Álvarez N; Fitó Fruitós A; Rodríguez Rodríguez J; Domíngo Salvany A; de la Torre Fornell R
    Forensic Sci Int; 2016 Jun; 263():164-168. PubMed ID: 27129144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A contribution to the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets.
    Gimeno P; Besacier F; Chaudron-Thozet H; Girard J; Lamotte A
    Forensic Sci Int; 2002 Jun; 127(1-2):1-44. PubMed ID: 12098525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological content of tablets sold as "ecstasy": results from an online testing service.
    Tanner-Smith EE
    Drug Alcohol Depend; 2006 Jul; 83(3):247-54. PubMed ID: 16364567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid chromatographic and mass spectral analysis of N-substituted analogues of 3,4-methylenedioxyamphetamine.
    Noggle FT; Clark CR; Valaer AK; DeRuiter J
    J Chromatogr Sci; 1988 Aug; 26(8):410-5. PubMed ID: 3215990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid chromatographic and mass spectral analysis of 1-(3,4-methylenedioxyphenyl)-1-propanamines: regioisomers of the 3,4-methylenedioxyamphetamines.
    DeRuiter J; Clark CR; Noggle FT
    J Chromatogr Sci; 1990 Mar; 28(3):129-32. PubMed ID: 2273067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clandestine drug laboratory situation in the United States.
    Frank RS
    J Forensic Sci; 1983 Jan; 28(1):18-31. PubMed ID: 6680736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration.
    Kintz P
    J Anal Toxicol; 1997; 21(7):570-5. PubMed ID: 9399128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of di(beta-phenylisopropyl)amine as the main ingredient in illicit amphetamine tablets.
    Ottaviano V; Furnari C; Rosati F
    Ann Ist Super Sanita; 2002; 38(3):331-5. PubMed ID: 12645186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mCPP: an undesired addition to the ecstasy market.
    Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
    J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Biochem Pharmacol; 2009 Jun; 77(11):1725-34. PubMed ID: 19428327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
    Matsushima K; Nagai T; Kamiyama S
    J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
    Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
    Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.